• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-羟基丙烯酰胺衍生物的合成及对人二氢乳清酸脱氢酶的抑制作用

Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase.

作者信息

Kim Taek Hyeon, Na Hye-Sun, Löffler Monika

机构信息

Department of Applied Chemistry, College of Engineering, Chonnam National University, Gwangju 500-757, Korea.

出版信息

Arch Pharm Res. 2003 Mar;26(3):197-201. doi: 10.1007/BF02976829.

DOI:10.1007/BF02976829
PMID:12723931
Abstract

Novel beta-hydroxy propenamides as analogues of the active metabolite of leflunomide (A 771726) were synthesized and evaluated for their inhibitory activity on dihydroorotate dehydrogenase (DHODH) in an investigation into their immunosuppressive activity. Compounds 2a, 3a, and 3h were approximately 4-40 times more potent than leflunomide in their activity while they were-less active than A 771726.

摘要

合成了新型β-羟基丙烯酰胺作为来氟米特活性代谢物(A 771726)的类似物,并在对其免疫抑制活性的研究中评估了它们对二氢乳清酸脱氢酶(DHODH)的抑制活性。化合物2a、3a和3h的活性比来氟米特强约4至40倍,但其活性低于A 771726。

相似文献

1
Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase.β-羟基丙烯酰胺衍生物的合成及对人二氢乳清酸脱氢酶的抑制作用
Arch Pharm Res. 2003 Mar;26(3):197-201. doi: 10.1007/BF02976829.
2
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.来氟米特的免疫抑制代谢产物是人类二氢乳清酸脱氢酶的强效抑制剂。
Biochemistry. 1996 Jan 30;35(4):1270-3. doi: 10.1021/bi952168g.
3
Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis.来氟米特的活性代谢产物诱导 EMT 样表型及其在肺纤维化中的作用。
Cell Death Differ. 2010 Dec;17(12):1882-95. doi: 10.1038/cdd.2010.64. Epub 2010 May 21.
4
Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.免疫抑制异恶唑和喹啉酸衍生物对人和大鼠二氢乳清酸脱氢酶的种属相关抑制作用。
Biochem Pharmacol. 1998 Nov 1;56(9):1259-64. doi: 10.1016/s0006-2952(98)00145-2.
5
3D-QSAR studies on a series of dihydroorotate dehydrogenase inhibitors: analogues of the active metabolite of leflunomide.一系列二氢乳清酸脱氢酶抑制剂的3D-QSAR研究:来氟米特活性代谢物的类似物
Int J Mol Sci. 2011;12(5):2982-93. doi: 10.3390/ijms12052982. Epub 2011 May 10.
6
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review.二氢乳清酸脱氢酶(DHODH)抑制剂“来氟米特”和“特立氟胺”在新冠病毒感染中的疗效和安全性:一项叙述性综述。
Eur J Pharmacol. 2021 Sep 5;906:174233. doi: 10.1016/j.ejphar.2021.174233. Epub 2021 Jun 7.
7
Suppression of immunoglobulin production by a novel dihydroorotate dehydrogenase inhibitor, S-2678.新型二氢乳清酸脱氢酶抑制剂S-2678对免疫球蛋白产生的抑制作用
Eur J Pharmacol. 2008 Dec 28;601(1-3):163-70. doi: 10.1016/j.ejphar.2008.09.010. Epub 2008 Sep 20.
8
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.免疫抑制剂来氟米特对二氢乳清酸脱氢酶的抑制作用。
Biochem Pharmacol. 1995 Sep 7;50(6):861-7. doi: 10.1016/0006-2952(95)00255-x.
9
Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.对人类二氢乳清酸脱氢酶上布喹那和来氟米特结合位点的多重抑制剂分析。
Biochemistry. 2001 Feb 20;40(7):2194-200. doi: 10.1021/bi001810q.
10
Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.来氟米特抑制PDK1/Akt信号通路并诱导人肥大细胞凋亡。
J Immunol. 2007 Nov 15;179(10):6479-84. doi: 10.4049/jimmunol.179.10.6479.